Fibromyalgia
7 competing products in clinical development for Fibromyalgia.
Pipeline by Phase
Phase 23
Phase 33
Approved1
All Products (7)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| ONO-1110 + Placebo | Ono Pharmaceutical | Phase 2 | Recruiting | 42 |
| DS-5565 + Placebo | Daiichi Sankyo | Phase 3 | Completed | 40 |
| Duloxetine | Shionogi | Phase 3 | Completed | 40 |
| Duloxetine 60 mg + Placebo | Shionogi | Phase 3 | Completed | 40 |
| ASP8062 + Placebo | Astellas Pharma | Phase 2 | Completed | 35 |
| ASP0819 + Placebo | Astellas Pharma | Phase 2 | Completed | 35 |
| zonisamide | Eisai | Approved | Withdrawn | 35 |